AngioDynamics Inc (ANGO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AngioDynamics Inc (ANGO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7114
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AngioDynamics Inc (AngioDynamics) is a provider of minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. Its products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through direct sales force in the US and through a network of distributors outside the US. It has operations in North America, Europe and Asia. AngioDynamics is headquartered in New York, the US.

AngioDynamics Inc (ANGO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AngioDynamics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AngioDynamics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AngioDynamics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AngioDynamics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AngioDynamics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AngioDynamics Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
AngioDynamics Acquires BioSentry Tract Sealant System from Surgical Specialties 10
AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 11
Partnerships 12
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 12
Kimal Extends Distribution Agreement With AngioDynamics For Vascular Access Products 13
Kimal Enters Into Distribution Agreement With AngioDynamics For Fluid Management And Vascular Products 14
AngioDynamics Enters Into Co-Marketing Agreement With Microsulis Medical 15
Equity Offering 16
AngioDynamics Prices Public Offering of Shares for USD38 Million 16
AngioDynamics Prices Public Offering of Shares for USD32 Million 17
Acquisition 19
AngioDynamics to Acquire RadiaDyne 19
AngioDynamics Acquires Clinical Devices 20
AngioDynamics Completes Acquisition Of Vortex Medical, Endomechanical Device Developer 21
AngioDynamics Acquires Navilyst Medical From Avista Capital For US$355 Million 22
AngioDynamics Inc – Key Competitors 24
AngioDynamics Inc – Key Employees 25
AngioDynamics Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Strategy And Business Planning 28
Sep 17, 2018: AngioDynamics to buy patient dose monitoring firm RadiaDyne 28
Financial Announcements 29
Sep 27, 2018: AngioDynamics reports fiscal 2019 first quarter financial results 29
Jul 11, 2018: AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results 30
Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 32
Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 34
Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 35
Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 36
Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 38
Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 39
Legal and Regulatory 41
May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 41
Other Significant Developments 42
Aug 15, 2018: AngioDynamics provides updates on oncology and vascular access businesses 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
AngioDynamics Inc, Medical Equipment, Key Facts, 2018 2
AngioDynamics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AngioDynamics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AngioDynamics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AngioDynamics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AngioDynamics Inc, Deals By Market, 2012 to YTD 2018 8
AngioDynamics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AngioDynamics Acquires BioSentry Tract Sealant System from Surgical Specialties 10
AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 11
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 12
Kimal Extends Distribution Agreement With AngioDynamics For Vascular Access Products 13
Kimal Enters Into Distribution Agreement With AngioDynamics For Fluid Management And Vascular Products 14
AngioDynamics Enters Into Co-Marketing Agreement With Microsulis Medical 15
AngioDynamics Prices Public Offering of Shares for USD38 Million 16
AngioDynamics Prices Public Offering of Shares for USD32 Million 17
AngioDynamics to Acquire RadiaDyne 19
AngioDynamics Acquires Clinical Devices 20
AngioDynamics Completes Acquisition Of Vortex Medical, Endomechanical Device Developer 21
AngioDynamics Acquires Navilyst Medical From Avista Capital For US$355 Million 22
AngioDynamics Inc, Key Competitors 24
AngioDynamics Inc, Key Employees 25
AngioDynamics Inc, Other Locations 26
AngioDynamics Inc, Subsidiaries 26

List of Figures
AngioDynamics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AngioDynamics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AngioDynamics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AngioDynamics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AngioDynamics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AngioDynamics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AngioDynamics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AngioDynamics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AngioDynamics Inc (ANGO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vital Images Inc:企業の戦略的SWOT分析
    Vital Images Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • QEP Resources, Inc. (QEP):石油・ガス:M&Aディール及び事業提携情報
    Summary QEP Resources Inc (QEP) is an independent oil and natural gas exploration and production company. It has operating interests in Northern Region chiefly in North Dakota, Wyoming and Utah; and Southern Region essentially in Texas and Louisiana. In Northern Region, the company owns productive w …
  • TPF SA:企業の戦略的SWOT分析
    TPF SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • PT Bank Permata Tbk:企業の戦略・SWOT・財務分析
    PT Bank Permata Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Permata Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • Sao Paulo Alpargatas S.A.:戦略・SWOT・企業財務分析
    Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report Summary Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Enercon Services Inc:企業の戦略的SWOT分析
    Enercon Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Johnson Outdoors Inc (JOUT):企業の財務・戦略的SWOT分析
    Johnson Outdoors Inc (JOUT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Innergex Renewable Energy Inc:企業の発電所・SWOT分析2018
    Innergex Renewable Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …
  • Total SA (FP)-エネルギー分野:企業M&A・提携分析
    Summary Total S.A. (Total) is an integrated global oil and gas company that produces, refines and markets oil, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distribution of petrole …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • BioDiem Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal dis …
  • AB Volvo:企業の戦略・SWOT・財務情報
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • FGL Sports Ltd. :企業の戦略・SWOT・財務情報
    FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report Summary FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Jitsubo Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jitsubo Co Ltd (Jitsubo), a subsidiary of Sosei Group Corp, is a biotechnology company that develops, manufactures and commercializes peptide therapeutics. The company’s molecular hiving technology modifies the polysaccharide and sugar chain peptide sequence. Its Molecular Hiving technology …
  • Space Exploration Technologies Corp:企業の戦略・SWOT・財務情報
    Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • ImaginAb Inc:医療機器:M&Aディール及び事業提携情報
    Summary ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務分析
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆